TranSenda International LLC, a provider of clinical trial management software (CTMS) solutions, has been sold to BioClinica, a global provider of clinical trial management services, for an undisclosed consideration.
This acquisition is strategic in improving efficiencies for BioClinica's customers by reducing study duration and costs through integrated operational management.
Oaklins' team in Seattle initiated the transaction, assisted in the negotiations and acted as financial advisor to the seller in this transaction.
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.